CClinicalTrials.gg
CompletedNCT02657135TEAM-TBIUpdated Jul 23, 2018

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

An interventional study of Cognitive/Neuropsychological Testing and Vestibular/Ocular-Motor Testing in Traumatic Brain Injury (TBI), sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-07-23.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Mar 2014, registered Jul 2015).
Phase
Not applicable
Study type
Interventional
Enrollment
95
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) is a research study that brings together TBI patients, advanced evaluation methods, and experts in a multi-faceted study to address the heterogeneity of TBI and to evaluate the effects self-help strategies might have on TBI outcomes.

Read the detailed description

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) proposes a new approach to clinical trials in TBI that will:

  • Evolve diagnostic technology \& treatment
  • Improve self-help strategies
  • Lower cost and speed for delivery of effective strategies

The TEAM-TBI program proposes an innovative new approach to TBI clinical trials to overcome the limitations of past efforts and achieve long-awaited breakthroughs for TBI survivors. The study will involve a comprehensive 3-4 day intake evaluation, followed by a variety of remotely performed tasks during a 1-6 month follow-up period.

02

Conditions studied

03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 95 is above the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18-60 years of age
  • Fluent in English
  • Documented history of TBI or blast exposure since 2001

Exclusion criteria

Exclusion Criteria:

  • Inability to have MRI
  • Pregnancy
  • History of TIA within last 6 months.
  • Presently involved in open litigation
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
95 participants (actual)

Study arms

  • Experimental
    History of Traumatic Brain Injury

    All participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.

    Behavioral: Cognitive/Neuropsychological Testing · Other: Vestibular/Ocular-Motor Testing · Other: Cervical (Neck) Evaluation · Other: Sleep Evaluation · Other: HDFT MRI · Other: MR Spectroscopy (MRS) · Other: MEG (Magnetoencephalography)

Interventions

  • BehavioralCognitive/Neuropsychological Testing

    These tests will be used to determine how the participant will continue with future procedures, and depending on results, may involve the participant returning to complete subsequent testing.

  • OtherVestibular/Ocular-Motor Testing

    These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI and will include dizziness, balance, ocular-motor coordination, and reflexes.

  • OtherCervical (Neck) Evaluation

    These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI including neck mobility and pain levels.

  • OtherSleep Evaluation

    These evaluations will focus on assessing insomnia (duration, frequency, daytime consequences), combat exposure, and the presence and severity of trauma history.

  • OtherHDFT MRI

    This MRI aims at providing qualitative and quantitative assessments of the nature, location, and extent of white matter injury.

  • OtherMR Spectroscopy (MRS)

    This is a noninvasive diagnostic test for measuring biochemical changes in the brain.

  • OtherMEG (Magnetoencephalography)

    This is a non-invasive neurophysiological technique that measures the magnetic fields generated by neuronal activity of the brain.

06

What researchers measure

Primary outcomes

  1. The main outcome variable in the study will be the change in Post-Concussion Symptom Scale (PCSS) score from the initial intake evaluation compared to last follow-up evaluation.

    Time frame: Up to 6 months

Secondary outcomes

  1. Change in the Satisfaction with Life Scale

    Time frame: Up to 6 months

07

Study locations

1 site
  • University of Pittsburgh Neurotrauma Clinical Trials Center
    Pittsburgh, Pennsylvania 15213, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02657135
Lead sponsor
University of Pittsburgh
Collaborators
United States Department of Defense
Responsible party
David Okonkwo, MD, Phd (Professor, University of Pittsburgh) — Principal investigator
First posted
Jan 15, 2016
Start date
Mar 24, 2014
Primary completion
Mar 23, 2018
Completion
Mar 23, 2018
Last update
Jul 23, 2018

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion